Market revenue in 2023 | USD 489.3 million |
Market revenue in 2030 | USD 2,194.5 million |
Growth rate | 23.9% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 53.98% in 2023. Horizon Databook has segmented the U.S. next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is witnessing rapid developments in NGS data analysis methodologies for applications in oncology and infectious diseases, which is expected to boost the market in the country. Furthermore, the large revenue share of the U.S. can also be attributed to the presence of market leaders, such as Illumina, Roche, Thermo Fisher, and Agilent Technologies, which are involved in various strategic initiatives to boost their market share.
For instance, in June 2020, Illumina acquired a cloud-based software company, Blue Bee, which offers genomics analysis solutions for clinical & research applications. This acquisition integrated the capabilities of Blue Bee into cloud portfolio of Illumina to provide flexibility to its customers during data processing.
Moreover, in February 2021, QIAGEN announced strategic partnerships with five different companies with an aim to consolidate its digital genome knowledge base. The new partnerships are aimed at delivering Al-based NGS data analysis services for oncology.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account